CF PharmTech

Cf Pharmtech is a high-tech innovative pharmaceutical enterprise that focuses on the development of inhalation drug delivery technology, integrating research and development, production, and sales. Its R&D pipeline covers a full range of products for the respiratory system, including several therapeutic areas with significant clinical demand: Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Allergic Rhinitis. The company owns four major R&D and production platforms for inhalation formulations: Metered-Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Nebulizers, and Nasal Sprays, with the goal of becoming a leading company in drug research and production within this field.